Adaptive Biotechnologies Corporation (ADPT)
NASDAQ·Healthcare·Biotechnology
$16.64
-3.48%
Mkt Cap $2.73B
Analyst Ratings
Buy
7
Hold
1
Sell
0
Price Target (11 analysts)
$21.25
Range $21.00 – $22.00
Implied Upside
+27.7%
Consensus $21.25 vs current $16.64